Document is current
Any future updates will be listed below
-
Authors
Fernàndez-López, Laura http://orcid.org/0000-0002-6353-3942
Reyes-Urueña, Juliana
Egea, Laia
Chernyshev, Andrii
Upmace, Inga
Ćosić, Mitja
Mejías, William
González, Victoria
Blondeel, Karel
Thwin, Soe Soe
Gios, Lorenzo
Mirandola, Massimo
Peeling, Rosanna
Kiarie, James
Casabona, Jordi
Toskin, Igor
,
- License Information
-
More Information
Article History
Received: 15 September 2022
Accepted: 11 January 2024
First Online: 29 February 2024
Declarations
:
: The study has been independently peer reviewed and approved by the Research Project Review Panel (RP2) of the WHO Department of Sexual and Reproductive Health and Research (SRH) and by the WHO Ethics Review Committee (ERC), and by ethics committees in each country. Autonomy of the users to decide to participate in the study was safeguarded by the division of the roles of taking pre-consent on the one hand and performing the study on the other. The final consent was taken by the CBO testing service provider who performs the test, as they also checked if the user met the inclusion criteria, for confidentiality reasons.
: Not applicable.
: The POCT manufacturers furnished sufficient quantities of the product(s) free of charge in order to enable this evaluation as part of the WHO/RHR STI POC initiative. WHO is entitled to evaluate and publish the trial results, and to exclusively control this evaluation and the content of the publication. WHO shall submit any proposed publication to the manufacturers for review, comments received will be considered in good faith, but the decision to publish rests with WHO.
